Results 101 to 110 of about 5,269 (122)

NASH limits anti-tumour surveillance in immunotherapy-treated HCC

Nature, 2021
Dominik Pfister, , Roser Pinyol
exaly  

Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH

Nature, 2021
Michael Dudek   +2 more
exaly  

Challenges and opportunities in NASH drug development

Nature Medicine, 2023
Stephen Harrison, Julie Dubourg
exaly  

A researcher’s guide to preclinical mouse NASH models

Nature Metabolism, 2022
Suchira Gallage, , Enrico Focaccia
exaly  

Maladaptive regeneration — the reawakening of developmental pathways in NASH and fibrosis

Nature Reviews Gastroenterology and Hepatology, 2020
Changyu Zhu   +2 more
exaly  

From NASH to HCC: current concepts and future challenges

Nature Reviews Gastroenterology and Hepatology, 2019
Quentin M Anstee, Frcp   +2 more
exaly  

Home - About - Disclaimer - Privacy